Linlin Dai

Statistics

Publications

Citations

131

H-Index

Active since

2015

Affiliations

Tianjin Institute of Pharmaceutical Research (China)(Current)

Tianjin Medical University Cancer Institute and Hospital

Linlin Dai is an author at Tianjin Institute of Pharmaceutical Research (China) specializing in chemistry, natural sciences, and transition metal complexes.

ORCID

Publications per year

2015–2021

Publications

Novel Copper Complexes That Inhibit the Proteasome and Trigger Apoptosis in Triple-Negative Breast Cancer Cells

Dongdong Li, Ernesto Yagüe, Luyao Wang et al. · ACS Medicinal Chemistry Letters · 2019 · 56 citations · Full text

Natural Sciences, Oncology, Pharmacology +16

Synthesis, structure–activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents

Dongdong Li, Linlin Dai, Na Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 21 citations

Pharmacy, Chemistry, Medicinal Chemistry +15

Synthesis, DNA binding, nuclease activity and cytotoxic studies of a wheel‐shaped octanuclear copper(II) complex based on 1,2,4‐triazole

Dongdong Li, Na Zhang, Linlin Dai et al. · Applied Organometallic Chemistry · 2016 · 16 citations

Natural Sciences, Chemistry, Oncology +17

Scalable, Telescoped Hydrogenolysis–Enzymatic Decarboxylation Process for the Asymmetric Synthesis of (<i>R</i>)-α-Heteroaryl Propionic Acids

Caroline A. Blakemore, Scott P. France, Lacey Samp et al. · Organic Process Research & Development · 2020 · 16 citations

Natural Sciences, Biochemistry, Chemistry +10

Sophoridine Derivatives Induce Apoptosis and Autophagy to Suppress the Growth of Triple‐Negative Breast Cancer through Inhibition of mTOR Signaling

Linlin Dai, Luyao Wang, Cheng Tan et al. · ChemMedChem · 2021 · 12 citations

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 6